Key result
Admission hyperglycemia is linked to higher 1-year stent restenosis readmissions after primary PCI in STEMI.
Why the study?
Hyperglycemia adversely affects STEMI clinical outcomes, so this study investigated the impact of admission hyperglycemia on the risk of restenosis after primary PCI across diabetic and non-diabetic patients.
Does admission hyperglycemia (>140 mg/dL) increase the 1-year risk of rehospitalization for stent restenosis after primary PCI in STEMI patients with or without diabetes compared to normoglycemic patients?
Cohort (n=336)
No
Does admission hyperglycemia (>140 mg/dL) increase the 1-year risk of rehospitalization for stent restenosis after primary PCI in STEMI patients with or without diabetes compared to normoglycemic patients?
Admission hyperglycemia (>140 mg/dL) in STEMI patients undergoing primary PCI is independently associated with more than double the 1-year risk of stent restenosis rehospitalization, even in the absence of diabetes mellitus.
Answers are grounded in this paper and cite their sources.
Admission hyperglycemia was associated with higher restenosis rehospitalization after STEMI PCI; leaves open whether glycemic control reduces risk in prospective trials.
ST-elevation myocardial infarction (STEMI) is one of the leading causes of death and hospitalization worldwide. Hyperglycemia (HG) has been shown to adversely affect STEMI clinical outcomes, leading to higher mortality and severe complications . The aim of our study was to investigate the impact of HG at hospital admission on the risk of restenosis after primary percutaneous coronary intervention (PCI) for STEMI, comparing normoglycemic subjects (NG group), patients without diabetes mellitus (DM) but with HG (HG-non-DM group), and patients with both HG and DM (HG-DM group).
No takes yet. Share an insight, caveat, or question.
Mone et al. (2021) conducted a cohort in ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (n=336). Admission hyperglycemia (glycemia >140 mg/dL) with or without diabetes mellitus vs. Normoglycemic subjects (glycemia ≤140 mg/dL) was evaluated on Rehospitalization for acute coronary syndrome confirmed to be due to stent restenosis at 1 year (p=0.009). Admission hyperglycemia increased 1-year stent restenosis rehospitalization after primary PCI in STEMI patients without diabetes and with diabetes vs normoglycemia.
Synapse has enriched 10 related papers. Consider them for comparative context: